Bio-Techne (TECH) Total Liabilities (2009 - 2026)
Bio-Techne's (TECH) quarterly Total Liabilities came in at $2.6 billion in Q1 2026, down 3.54% year-on-year from $2.6 billion in Q1 2025, and up 1.11% quarter-over-quarter from $2.5 billion in Q4 2025.
Bio-Techne (TECH) Total Liabilities (2009 - 2026) Analysis & Trends
Bio-Techne's Total Liabilities history runs 18 years deep, the most recent figure standing at $2.6 billion for Q1 2026.
- On a quarterly basis, Total Liabilities fell 3.54% year-over-year to $2.6 billion in Q1 2026; TTM through Mar 2026 was $2.6 billion, a 3.54% decrease from a year earlier, with the FY2025 full-year figure at $2.6 billion, down 5.4% from the prior year.
- Total Liabilities climbed to $2.6 billion in Q1 2026 per TECH's latest filing, from $2.5 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $2.8 billion in Q3 2023 and bottomed at $2.3 billion in Q2 2022.
- The 5-year median for Total Liabilities is $2.6 billion (2023), against an average of $2.6 billion.
- Across the five-year window, Total Liabilities increased 17.21% in 2023 and decreased 7.67% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $2.4 billion in 2022, then climbed by 15.54% to $2.7 billion in 2023, then fell by 2.21% to $2.7 billion in 2024, then retreated by 5.53% to $2.5 billion in 2025, then rose by 1.11% to $2.6 billion in 2026.
- Per Business Quant, the three latest TECH Total Liabilities figures stand at $2.6 billion (Q1 2026), $2.5 billion (Q4 2025), and $2.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 2.55 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.55 Bn |
| Dec 31, 2025 | 2.52 Bn |
| Sep 30, 2025 | 2.53 Bn |
| Jun 30, 2025 | 2.56 Bn |
| Mar 31, 2025 | 2.64 Bn |
| Dec 31, 2024 | 2.67 Bn |
| Sep 30, 2024 | 2.74 Bn |
| Jun 30, 2024 | 2.70 Bn |
| Mar 31, 2024 | 2.72 Bn |
| Dec 31, 2023 | 2.73 Bn |
| Sep 30, 2023 | 2.76 Bn |
| Jun 30, 2023 | 2.64 Bn |
| Mar 31, 2023 | 2.60 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.35 Bn |
| Jun 30, 2022 | 2.29 Bn |
| Mar 31, 2022 | 2.30 Bn |
| Dec 31, 2021 | 2.30 Bn |
| Sep 30, 2021 | 2.27 Bn |
| Jun 30, 2021 | 2.26 Bn |